Pharmaceutical Stocks List


Related Industries: Asset Management Biotechnology Business Services Chemicals Data Storage Diagnostics & Research Diversified Industrials Drug Manufacturers - General Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Farm & Construction Equipment Health Information Services Household & Personal Products Information Technology Services Internet Content & Information Lumber & Wood Production Medical Devices Medical Distribution Medical Instruments & Supplies Packaging & Containers Pharmaceutical Retailers Pharmaceutical Retailers Pollution & Treatment Controls Security & Protection Services Semiconductor Equipment & Materials Software - Application Specialty Chemicals Specialty Finance Steel Waste Management

Related ETFs - A few ETFs which own one or more of the above listed Pharmaceutical stocks.

Pharmaceutical Stocks Recent News

Date Stock Title
May 20 SABS SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates
May 20 PHAR Pharming Group to participate in May investor conference
May 18 OPTN OptiNose, Inc. (OPTN) Q1 2024 Earnings Call Transcript
May 17 OPTN Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
May 17 QLI Qilian International plans to adjust industrial investment
May 17 ASRT Assertio to Participate in Benchmark Healthcare Conference on May 21-22
May 17 ASRT BUXTON HELMSLEY RELEASES LETTER FROM CERTIFIED FRAUD EXAMINER ATTESTING TO DISCLOSURE FAILURES AND DEFICIENCIES BY ASSERTIO HOLDINGS BOARD OF DIRECTORS
May 16 ASRT Assertio to Participate in AGP Healthcare Conference on May 21
May 16 NOTV Inotiv, Inc. (NOTV) Q2 2024 Earnings Call Transcript
May 15 NOTV Inotiv GAAP EPS of -$1.86 misses by $1.32, revenue of $119M misses by $14.08M
May 15 NOTV Inotiv Reports Second Quarter Financial Results for Fiscal 2024 and Provides Business Update
May 15 DNA Ginkgo slips as BTIG cuts to Sell on strategic shift
May 15 DNA Ginkgo Bioworks to Participate in Two Conferences in May
May 15 OPTN Q1 2024 OptiNose Inc Earnings Call
May 15 OPTN OptiNose Inc (OPTN) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Financial ...
May 15 PHAR Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025
May 14 DNA Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in Japan
May 14 NOTV Inotiv tumbles 50% on revenue outlook, business update
May 14 OPTN OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates
May 14 OPTN Optinose GAAP EPS of -$0.12, revenue of $14.88M
Pharmaceutical

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
Drugs are classified in various ways. One of the key divisions is by level of control, which distinguishes prescription drugs (those that a pharmacist dispenses only on the order of a physician, physician assistant, or qualified nurse) from over-the-counter drugs (those that consumers can order for themselves). Another key distinction is between traditional small-molecule drugs, usually derived from chemical synthesis, and biopharmaceuticals, which include recombinant proteins, vaccines, blood products used therapeutically (such as IVIG), gene therapy, monoclonal antibodies and cell therapy (for instance, stem-cell therapies). Other ways to classify medicines are by mode of action, route of administration, biological system affected, or therapeutic effects. An elaborate and widely used classification system is the Anatomical Therapeutic Chemical Classification System (ATC system). The World Health Organization keeps a list of essential medicines.
Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions, drug pricing. Controversies have arisen over drug pricing and disposal of used drugs.

Browse All Tags